OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Goldman on the Impact of Liquid Biopsies in Lung Cancer

March 4th 2020

Jonathan W. Goldman, discusses the impact of liquid biopsies in lung cancer.

Dr. O'Donnell on Unanswered Questions in Multiple Myeloma

March 4th 2020

Betsy O’Donnell, MD, discusses unanswered questions in multiple myeloma.

Using Trapelo to Maintain Molecular Testing Guidelines for Ovarian Cancer

March 4th 2020

Lori Brisbin, discusses using Trapelo, an automated tool to track precision medicine guidelines in various cancers, in patients with ovarian cancer.

Dr. Khan on Retrospective Analysis of Demographics in CRC and Gastric Cancer

March 4th 2020

Amir Khan, MD, discusses a large retrospective database analysis on colorectal cancer and gastric cancer presented at the 2020 Gastrointestinal Cancers Symposium.

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast Cancer

March 4th 2020

Sara M. Tolaney, MD, MPH, discusses novel approaches in treating patients with HER2-positive breast cancer.

Dr. Pagel on Time-Limited Therapy in CLL

March 4th 2020

John M. Pagel, MD, PhD, discusses time-limited therapy in chronic lymphocytic leukemia.

Dr. Mirhadi on Patient Populations of Lung Cancer Optimal for Radiation

March 4th 2020

Amin J. Mirhadi, MD, discusses patient populations of lung cancer who should be treated with radiation therapy.

Dr. Lee on Treatment Options mRCC

March 4th 2020

Chung-Han Lee, MD, PhD, discusses treatment options for patients with metastatic renal cell carcinoma.

Dr. Katz on Preoperative Chemotherapy in Resectable Pancreatic Cancer

March 4th 2020

Matthew H.G. Katz, MD, FACS, discusses the utility of preoperative chemotherapy for patients with resectable pancreatic cancer.

Dr. Dahut on an NCI-Led Study Using MRI Screening to Detect Prostate Cancer

March 4th 2020

William L. Dahut, MD, senior investigator and section chief, Genitourinary Malignancies Branch, head, Prostate Cancer Clinical Research Section, clinical director and scientific director for clinical research, Center for Cancer Research, National Cancer Institute (NCI), discusses an NCI-led study that is using screening to detect prostate cancer.

Dr. Lopategui on the Implications of Genomic Sequencing in Lung Cancer

March 4th 2020

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the implications of genomic sequencing in lung cancer.

Dr. Moore on the Role of Mirvetuximab Soravtansine in Ovarian Cancer

March 4th 2020

Kathleen Moore, MD, director, Oklahoma TSET Phase I Clinical Trials Program, and associate professor, Section of Gynecologic Oncology, Jim and Christy Everest Endowed Chair in Cancer Research, director, Gynecologic Oncology Fellowship Program, associate director of Clinical Research, and medical director of the Clinical Trials Office, at Stephenson Cancer Center, discusses the role of mirvetuximab soravtansine in platinum-resistant ovarian cancer.

Dr. Wright on Key Strategies in Using Radiation in Breast Cancer Treatment

March 3rd 2020

Jean Wright, MD, discusses key strategies in using radiation therapy to treat patients with breast cancer.

Dr. Chung on the Effect of Combo Therapies in Patients With Pancreatic Cancer

March 3rd 2020

Vincent Chung, MD, discusses the effect of gemcitabine, nab-paclitaxel (Abraxane), metformin, and dietary supplements on patients with pancreatic cancer.

Dr. Goodman on the Role of Transplant in T-Cell Lymphoma

March 3rd 2020

Aaron Goodman, MD, hematologist/oncologist and assistant professor of medicine at the University of California, San Diego, discusses the role of transplant in patients with T-cell lymphomas.

Dr. Branagan on Tandem Transplants in Multiple Myeloma

March 3rd 2020

Andrew Branagan, MD, discusses the research tandem transplants in patients with high-risk multiple myeloma.

Dr. Natale on the Utility of PD-L1 and TMB in Lung Cancer

March 3rd 2020

Ronald B. Natale, MD, medical director, Clinical Lung Cancer Program and assistant clinical professor of medicine, Cedars-Sinai, discusses the utility of PD-L1 expression and tumor mutational burden (TMB) in lung cancer.

Dr. Gerds on the State of Treatment in MPNs

March 3rd 2020

Aaron Gerds, MD, assistant professor of medicine in the Hematology and Medical Oncology Department at the Cleveland Clinic Taussig Cancer Institute, discusses the state of treatment in myeloproliferative neoplasms (MPNs).

Dr. Wang on the Safety Profile of KTE-X19 in MCL

March 3rd 2020

Michael Wang, MD, discusses the safety profile of the CAR T-cell therapy KTE-X19 in patients with relapsed/refractory mantle cell lymphoma, according to results from the phase II ZUMA-2 trial.

Dr. Raphael on the Treatment Landscape of CLL

March 3rd 2020

Bruce G. Raphael, MD, discusses the treatment landscape of chronic lymphocytic leukemia.